Viewing Study NCT04623827



Ignite Creation Date: 2024-05-06 @ 3:24 PM
Last Modification Date: 2024-10-26 @ 1:49 PM
Study NCT ID: NCT04623827
Status: COMPLETED
Last Update Posted: 2021-06-23
First Post: 2020-09-19

Brief Title: Retrospective Study of Psychoattitudinal Patterns in Patients With Fibromyalgia Receiving Antalgic Therapy
Sponsor: University of Bologna
Organization: University of Bologna

Study Overview

Official Title: A Retrospective Study Concerning the Psycho-attitudinal Classification of Patients Suffering From Fibromyalgia Undergoing a Specialized Analgesic Treatment
Status: COMPLETED
Status Verified Date: 2021-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Fibromyalgia FM is a widespread and invalidating disease that requires a multidisciplinary approach Particularly the psychiatric component seems to influence the algological management of these patients Since January 2018 the HADS SF-36 IMSA TCI psycho-attitudinal questionnaires have been introduced in the Pain Therapy unit of Policlinico SantOrsola-Malpighi in an attempt to improve the care of patients diagnosed with FM

The aim of the study is to identify through retrospective evaluation of TCI tests and its subdomains compiled by patients with FM diagnosis Pain Avoidance and Pain Persistance personality patterns indicated in the literature Anxiety and Depression incidence is also observed through retrospective evaluation of HADS tests

Patients in the Antalgic Therapy Outpatient Clinic diagnosed with FM aged 18 years who have completed selfadministered psychoattitudinal tests from January 2018 to January 2019 were considered The data were collected in aggregate and extrapolated anonymously
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None